Asayesh Darou Active Pharmaceutical Ingredients Manufacturing Company is one of the specialized and strategic companies in the country’s pharmaceutical industry, focusing primarily on the production of Active Pharmaceutical Ingredients (API)—the essential substances forming the foundation for the manufacturing of finished medicines. By leveraging up-to-date technical knowledge, specialized human resources, and advanced infrastructure, the company has played a significant role in reducing the pharmaceutical industry’s dependence on imports, becoming a reliable supplier of raw materials for pharmaceutical companies.

In recent years, given the strategic importance of domestic API production and the country’s growing need for self-sufficiency in this field, Asayesh Darou, through precise planning and targeted investment, has successfully produced a diverse range of widely used APIs. These APIs are utilized in the production of vital and high-demand medicines and meet international quality standards.

The quality control laboratories at Asayesh Darou are equipped with advanced facilities, and all production processes are carried out under strict scientific, technical, and sanitary supervision. Compliance with GMP principles, conducting precise testing at various stages of production, and adherence to global pharmaceutical standards have made Asayesh Darou a trusted partner for many domestic pharmaceutical companies.

One of the company’s key priorities is Research and Development (R&D). Asayesh Darou’s research team continuously monitors the domestic and regional pharmaceutical markets, focusing on developing new formulations and optimizing production processes. This innovative approach enables the company not only to meet current market demands but also to provide advanced and customized solutions for special projects.

Extensive and effective collaborations with other pharmaceutical companies, universities, and research centers are among the strengths of the company. Asayesh Darou has been a pioneer not only in production but also in technology transfer and localization of complex API manufacturing technologies, playing a pivotal role in the sustainable development of the country’s pharmaceutical industry.

Increasing production capacity, enhancing product quality, expanding exports to regional markets, and contributing to national health projects are part of the company’s future vision. With an eye toward the future, Asayesh Darou strives to become a successful model in domestic API production—a model built on quality, trust, and expertise.

In summary, Asayesh Darou, with a clear mission in the path of domestic production, supporting the pharmaceutical industry, and improving public health, seeks to further increase its contribution to the advancement of the country’s pharmaceutical sector by relying on local capabilities and a development-oriented vision.